This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Children's Medical Center Corporation, Other. Active years: 2003-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Thousand Oaks, CA (US) (2003)
- Plano, TX (US) (2017 - 2023)
Company Filing History:
3 out of 1,076 
1 out of 834,601 Years Active: 2003-2023
Title: The Innovations of Jian Xu
Introduction
Jian Xu is a prominent inventor based in Plano, TX (US). He has made significant contributions to the field of medical research, particularly in the area of hemoglobinopathies. With a total of 4 patents to his name, Xu's work has the potential to impact the treatment of various blood disorders.
Latest Patents
One of Jian Xu's latest patents is titled "Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction." This patent provides methods and compositions for increasing fetal hemoglobin levels in a cell by disrupting BCL11A expression at the genomic level. Additionally, it outlines methods and compositions related to the treatment of hemoglobinopathies through the reinduction of fetal hemoglobin levels. This innovative approach could lead to new therapies for patients suffering from blood disorders.
Career Highlights
Throughout his career, Jian Xu has worked with notable organizations, including the Children's Medical Center Corporation. His research has focused on advancing medical treatments and improving patient outcomes in the field of hematology.
Collaborations
Jian Xu has collaborated with esteemed colleagues such as Stuart H. Orkin and Daniel E. Bauer. These partnerships have further enriched his research and contributed to the development of groundbreaking medical solutions.
Conclusion
Jian Xu's innovative work in the field of hemoglobinopathies showcases his dedication to advancing medical science. His patents and collaborations highlight the importance of research in developing effective treatments for blood disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile